Details for New Drug Application (NDA): 017533
✉ Email this page to a colleague
The generic ingredient in KLONOPIN is clonazepam. There are ten drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clonazepam profile page.
Summary for 017533
Tradename: | KLONOPIN |
Applicant: | Cheplapharm |
Ingredient: | clonazepam |
Patents: | 0 |
Suppliers and Packaging for NDA: 017533
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
KLONOPIN | clonazepam | TABLET;ORAL | 017533 | NDA | H2-Pharma, LLC | 61269-605 | 61269-605-10 | 100 TABLET in 1 BOTTLE, PLASTIC (61269-605-10) |
KLONOPIN | clonazepam | TABLET;ORAL | 017533 | NDA | H2-Pharma, LLC | 61269-610 | 61269-610-10 | 100 TABLET in 1 BOTTLE, PLASTIC (61269-610-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 017533
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cheplapharm | KLONOPIN | clonazepam | TABLET;ORAL | 017533-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | KLONOPIN | clonazepam | TABLET;ORAL | 017533-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Cheplapharm | KLONOPIN | clonazepam | TABLET;ORAL | 017533-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription